No effect of interleukin-2 on IgE levels given in addition to antiretroviral therapy in HIV-infected adults with CD4 >300 cells/mm3.

Ananworanich, Jintanat; Chantaphakul, Hiroshi; Teeratakulpisarn, Somsong; Siangphoe, Umaporn; Ubolyam, Sasiwimol; Chuenyam, Theshinee; Ungsedhaphan, Chaiwat; Lange, Joep; Cooper, David; Phanuphak, Praphan; Ruxrungtham, Kiat.
Asian Pac J Allergy Immunol ; 2005 Mar; 23(1): 23-8
Artículo en Inglés | IMSEAR | ID: sea-36854

Documentos relacionados

  1. No effect of interleukin-2 on IgE levels given in addition to antiretroviral therapy in HIV-infected adults with CD4 >300 cells/mm3.
  2. Interleukin-2 therapy in patients with HIV infection.
  3. Absolute decrease in regulatory T cells and low-dose interleukin-2 therapy: restoring and expanding regulatory T cells to treat systemic sclerosis: a 24-week study.
  4. Something old, something new: The marriage of PD-1 and IL-2.
  5. Adjunctive interleukin-2 for the treatment of drug-susceptible tuberculosis: a randomized control trial in China.
  6. PD-1 combination therapy with IL-2 modifies CD8<sup>+</sup> T cell exhaustion program.
  7. IL-2-based approaches to Treg enhancement.
  8. Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults.
  9. Low-dose interleukin-2 therapy: a promising targeted therapeutic approach for systemic lupus erythematosus.
  10. Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies.